Clinical models get better checks for unreliable patient group predictions
Diagnosing Low-Confidence Patient Profiles via Localized Harmful Covariate Shift Detection
Machine LearningArtificial Intelligence
Summary
Clinical prediction models can sometimes make unreliable predictions, especially for certain groups of patients. The authors created a combined approach to find which patient groups have low-confidence predictions and then check if specific changes in the patient data cause the problems. They tested this on several medical tasks and found that some shifts in data are only visible when looking at these specific patient groups, not overall. This helps identify who might be at risk from inaccurate model predictions.
What this means in practice
- •For hospital data teams: Identify specific patient groups where clinical models may give unreliable predictions due to hidden data shifts, improving safety monitoring before deployment.
- •For medical software developers: Enhance diagnostic tools in clinical AI software to flag low-confidence patient profiles and their causes, enabling targeted model reliability improvements.
Authors
Olivier Lefebvre, Hakima Laribi, Dan Poenaru, Martin Vallières
Abstract
Before deploying clinical prediction models, their reliability must be assessed to ensure safe use. Errors may arise from distribution shifts between training and deployment or from heterogeneous performance where the model systematically underperforms for certain patient subgroups. Yet most post-hoc diagnostic methods evaluate reliability only at the population level, checking whether the deployment data resemble the training data and whether the model performs well on average, without accounting for heterogeneity that may cause some patients to be disproportionately affected. We propose a unified diagnostic pipeline that combines both perspectives. MED3pa first discovers interpretable low-confidence patient profiles, and Detectron is then applied within each profile to test whether its degradation is associated with a detectable harmful covariate shift. Across three clinical prediction tasks and three injected subgroup shifts in MIMIC-IV, we find that shift detectability itself is informative. An injected age shift, undetectable at the population level, was nonetheless localized to specific degraded profiles, whereas sex- and race-related shifts were detected broadly and therefore offered little guidance for identifying the most affected patients.